J&J Wins FDA Nod for Erleada, the First Drug for Nonmetastatic Prostate Cancer Post author:Sam Post published:February 14, 2018 Post category:BioPharma Janssen got a little love from the FDA on Wednesday. Source: BioSpace You Might Also Like Asklepios BioPharma Launches New Biotech Actus Therapeutics December 14, 2017 Tonix Pharma Reports First Quarter 2017 Financial Results And Provides Programs Update May 14, 2017 Celgene Co-Founder Bags $23M for Johns Hopkins Spinout NexImmune January 1, 2018
